SBIR/STTR Research Award

Optimization of Codon-Pair Usage to Maximize Protein Expression in Plants

Award identifier 82871623b41dac7703e305cc390eb93c9bc3e84ecdd783d5f9fbb24825f0e2e2Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$145,410

Program and phase

SBIR · Phase I

Award year

2007

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Planet Biotechnology Incorporated
Proposal award date
Not reported
Contract end date
Not reported
UEI
KTJKPBE2H5H3
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Inexpensive therapeutic recombinant proteins, such as monoclonal antibodies, can be produced using plants as "biofactories." For reasons that are unclear, the yield of antibodies has been low in practical agricultural crops, such as tobacco. We hypothesize that such generally low expression can be improved by matching the codon pair preferences of the host with the codon pairs of the recombinant genes. Work in bacterial, yeast and mammalian protein translation systems demonstrated that translational step- times are controlled by tRNA-tRNA interactions in the ribosome and that these interactions are controlled by adjacent codons (codon pairs). Thus, a designed gene can control translational step-times and improve protein expression. This technology has not yet been applied in plants. We will assemble a database of protein coding regions from tobacco, and using an algorithm developed at UC Irvine, design an IgG heavy chain gene with optimal codon-pair usage for tobacco expression (a "hot-rod" gene). We will then compare expression in tobacco of the same IgG heavy chain encoded by the "hot- rod" gene, a gene codon-optimized for tobacco, and the native human gene. If successful, the result will be a general platform technology for the quick, easy, scalable production of therapeutic human antibodies in large quantities. Planet is developing tobacco-produced recombinant proteins against several diseases including: intoxication by Botulinum Neurotoxin A (BoNT/A), the most potent toxin known and a bio-terror agent, the common cold, dental caries and intoxication by Anthrax toxin, also a bio-terror agent. All of these product-candidates could benefit from a technology that would increase expression in plants, which would result in decreases in production and purification costs, making therapeutic antibodies more affordable and widely available.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

38 SBIR/STTR records share this UEI (2000–2024). Reported award amounts total $26,790,475. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Defense, Department of Agriculture

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.